近日,《Extel》(原《机构投资者Institutional Investor》)揭晓“2025年度亚洲最佳管理团队”评选榜单。凭借卓越表现,药明康德在18个行业的1,668家企业中脱颖而出,荣膺亚洲“最受尊崇企业Most Honored Company” Top10。同时,在医疗行业细分类别评选中,药明康德在“最佳首席执行官Best CEO”“最佳首席财务官Best CFO”“最佳董事会...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.